[Inflammation in high blood pressure].

Area of Science:

• Cardiovascular Science
• Immunology
• Hypertension Research

Context:

• Inflammation is a significant factor in cardiovascular diseases and hypertension.
• Hypertension involves hematological cells, chemotactic factors, and the renin-angiotensin system.
• Clinical hypertension evaluation includes screening for proinflammatory substances to assess cardiovascular risk.

Purpose:

• To highlight the role of inflammation in hypertension pathophysiology.
• To identify key inflammatory biomarkers for cardiovascular risk assessment in hypertensive individuals.
• To explain the mechanisms by which Interleukin-6 and C-reactive protein contribute to endothelial dysfunction and hypertension.

Summary:

• Inflammation contributes to cardiovascular disorders and high blood pressure through various cellular and systemic factors.
• Interleukin-6 (IL-6) and C-reactive protein (CRP) are crucial biomarkers for evaluating cardiovascular risk in hypertension.
• IL-6 mediates acute tissue responses to stress, while CRP activates complement, leading to endothelial dysfunction and hypertension.

Impact:

• Provides insight into the inflammatory basis of hypertension.
• Emphasizes the clinical utility of IL-6 and CRP in risk stratification.
• Contributes to understanding the molecular mechanisms linking inflammation to cardiovascular pathology.